RNAi therapy (Targeted Genetics)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameRNAi therapy (Targeted Genetics)
Drug Alias NameHuntington's disease therapy (Merck & Co/Targeting Genetics)Huntingtons disease therapy (Sirna)RNAi therapy (Merck & Co/Targeted Genetics)RNAi therapy (Sirna/Targeted Genetics)RNAi therapy for Huntington's disease (Sirna) +[6] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionHuntingtin modulators
TargetsHuntingtin
Therapy Area/IndicationsHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSirna Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSirna Therapeutics IncArmata Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsHuntington Disease

Other Information

ATC CodeN/A
Related LinksN/A